Amanda Adler
Professor of Diabetic Medicine and Health Policy
- Director of Diabetes Trials Unit
Recent publications
-
Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study.
Journal article
Bidulka P. et al, (2021), BMJ Open, 11
-
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
Journal article
Rahimi K. et al, (2021), The Lancet, 398, 1053 - 1064
-
Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89.
Journal article
Wamil M. et al, (2021), Diabetes Care, 44, 1877 - 1884
-
Accurate accounting of caplacizumab cost effectiveness – Authors' reply
Journal article
Hughes M. et al, (2021), The Lancet Haematology, 8
-
Adjusting for Nonadherence or Stopping Treatments in Randomized Clinical Trials.
Journal article
Adler AI. and Latimer NR., (2021), JAMA, 325, 2110 - 2111